URGN
UroGen Pharma Ltd.
$39.80
+0.61 (+1.56%)
At close · Jul 15
Market Cap
$1.96B
Shares
48,721,701
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-23 | 2026-06-22 | |
| 8-K | 2026-06-02 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| DEF 14A | 2026-04-30 | 2025-12-31 | |
| 8-K | 2026-03-02 | 2026-02-26 | |
| 8-K | 2026-03-02 | — | |
| 10-K | 2026-03-02 | 2025-12-31 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-08-27 | 2025-08-26 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| DEF 14A | 2025-07-15 | 2025-08-11 | |
| 8-K | 2025-07-03 | 2025-06-30 | |
| 8-K | 2025-06-13 | 2025-06-12 | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| 10-K/A | 2025-04-30 | 2024-12-31 | |
| 10-K | 2025-03-10 | 2024-12-31 | |
| 8-K | 2025-03-10 | — | |
| 8-K | 2025-02-20 | 2025-02-14 | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-10-09 | 2024-10-07 | |
| 8-K | 2024-09-24 | 2024-09-23 | |
| 8-K | 2024-09-13 | 2024-09-12 | |
| 8-K | 2024-08-15 | 2024-08-14 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-08-08 | 2024-08-06 | |
| DEF 14A | 2024-07-01 | 2024-08-07 | |
| 8-K | 2024-06-18 | 2024-06-17 | |
| 8-K | 2024-06-13 | — | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 10-K/A | 2024-04-29 | 2023-12-31 | |
| 8-K | 2024-03-14 | — | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 8-K | 2024-03-04 | — | |
| 8-K | 2024-03-01 | — | |
| 8-K | 2024-02-07 | — | |
| 8-K | 2024-01-17 | 2024-01-16 | |
| 8-K | 2024-01-02 | 2023-12-28 | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-09-11 | 2023-09-07 | |
| 10-Q | 2023-08-10 | 2023-06-30 |
Showing 1–50 of 104 filings